Table 1

Tabulation of laboratory parameters

Laboratory parametersValues in unit (normal range) on admissionValues in unit (normal range) 7 weeks later
Haemoglobin73 g/L (130–180)102 g/L (130–180)
Mean Corpuscular Volume90.6 fL (83–101)93.4 fL (83–101)
Mean Corpuscular Haemoglobin Concentration33.3 g/dL (31.5–34.5)33 g/dL (31.5–34.5)
White cell count11.6×109 /L (4–10)7.63×109 /L (4–10)
Platelets292×103 /µL (150–400)280×103 /µL (150–400)
aPTT78.7 s (25.4–38.4)27.1 s (25.4–38.4)
Prothrombin time (PT)13.1 s (9.62–12.18)10.6 s (9.62–12.18)
International normalised ratio1.260.97
Creatinine134 umol/L (45–84)
Serum albumin31 g/L (35–52)
Carcinoembryonic antigen6.2 ng/mL (<3)
Carbohydrate antigen (CA 19–9)<2 U/mL (<37)
Alpha fetoprotein1.5 ng/mL (<9)
Prostate-specific antigen9.234 ng/mL (<4)
Antinuclear antibodiesNegative
Beta-hCG (human chorionic gonadotropin)2.1 IU/L (<5)
C reactive protein8.8 mg/L (<5)
Total iron binding capacity41.4 umol/L
Serum iron7.6 umol/L
Unsaturated iron-binding capacity33.8 umol/L
Serum vitamin B12 level103 pmol/L (133–675)
Serum folate level12.9 nmol/L (>14.93)
Peripheral blood filmAnaemia with increased reticulocytes possibly secondary to underlying bleeding/blood loss. No evidence of haemolysis was seen. White blood cell changes suggest infection or inflammation.
FVIII assay6.7% (50–150)365.1% (50–150)
FVIII inhibitor7.5 BU<0.5 BU
Factor IX assay114.7% (86.4–128.4)
  • aPTT, activated partial thromboplastin time; FVIII, factor VIII.